AstraZeneca is set to enlist Germany's IDT Biologika as a contract manufacturer of its COVID-19 vaccine, two people familiar with the matter told Reuters, as Germany and the European Union seek to speed up an immunisation campaign that got off to a hobbled start.

IDT Biologika, based in Dessau-Rosslau in eastern Germany, produces viral vaccines for pharmaceutical companies, and has suffered a recent setback in developing its own vaccine against the coronavirus.
IDT Biologika and AstraZeneca declined to comment.